MedTrace Logo

Binge Eating and Chromium Study

NCT00904306 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2012-04-03

No results posted yet for this study

Summary

The purpose of this study is to test the feasibility and preliminary efficacy of a 6-month chromium picolinate (CrPic) treatment trial in binge eating disorder (BED).

Conditions

  • Binge Eating Disorder

Interventions

DIETARY_SUPPLEMENT

Sugar Pill

placebo oral tablet taken once per day

DIETARY_SUPPLEMENT

chromium picolinate

1000 ug/day chromium picolinate for 6 months

DIETARY_SUPPLEMENT

chromium picolinate

600 ug/day chromium picolinate

Sponsors & Collaborators

  • National Alliance for Research on Schizophrenia and Depression

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Kimberly A Brownley, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00904306 on ClinicalTrials.gov